1. Home
  2. AAME vs LGVN Comparison

AAME vs LGVN Comparison

Compare AAME & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlantic American Corporation

AAME

Atlantic American Corporation

HOLD

Current Price

$1.36

Market Cap

34.3M

Sector

Finance

ML Signal

HOLD

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$2.81

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAME
LGVN
Founded
1968
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Life Insurance
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.3M
21.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
AAME
LGVN
Price
$1.36
$2.81
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
★ $3.00
AVG Volume (30 Days)
61.9K
★ 145.0K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
★ 0.81%
N/A
EPS Growth
N/A
★ 50.76
EPS
★ 0.22
N/A
Revenue
★ $188,227,000.00
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.81
P/E Ratio
$5.95
★ N/A
Revenue Growth
★ 0.77
N/A
52 Week Low
$1.25
$0.48
52 Week High
$3.24
$7.60

Technical Indicators

Market Signals
Indicator
AAME
LGVN
Relative Strength Index (RSI) 47.48 40.53
Support Level $1.26 $0.61
Resistance Level $1.62 $7.45
Average True Range (ATR) 0.07 0.42
MACD 0.01 -0.58
Stochastic Oscillator 58.17 9.24

Price Performance

Historical Comparison
AAME
LGVN

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: